Unknown

Dataset Information

0

Molecular surveillance of antiviral drug resistance of influenza A/H3N2 virus in Singapore, 2009-2013.


ABSTRACT: Adamantanes and neuraminidase inhibitors (NAIs) are two classes of antiviral drugs available for the chemoprophylaxis and treatment of influenza infections. To determine the frequency of drug resistance in influenza A/H3N2 viruses in Singapore, large-scale sequencing of neuraminidase (NA) and matrix protein (MP) genes was performed directly without initial culture amplification. 241 laboratory-confirmed influenza A/H3N2 clinical samples, collected between May 2009 and November 2013 were included. In total, 229 NA (95%) and 241 MP (100%) complete sequences were obtained. Drug resistance mutations in the NA and MP genes were interpreted according to published studies. For the NAIs, a visual inspection of the aligned NA sequences revealed no known drug resistant genotypes (DRGs). For the adamantanes, the well-recognised S31N DRG was identified in all 241 MP genes. In addition, there was an increasing number of viruses carrying the combination of D93G+Y155F+D251V (since May 2013) or D93G (since March 2011) mutations in the NA gene. However, in-vitro NAI testing indicated that neither D93G+Y155F+D251V nor D93G alone conferred any changes in NAI susceptibility. Lastly, an I222T mutation in the NA gene that has previously been reported to cause oseltamivir-resistance in influenza A/H1N1/2009, B, and A/H5N1, was detected from a treatment-naïve patient. Further in-vitro NAI testing is required to confirm the effect of this mutation in A/H3N2 virus.

SUBMITTER: Lee HK 

PROVIDER: S-EPMC4311985 | biostudies-literature | 2015

REPOSITORIES: biostudies-literature

altmetric image

Publications

Molecular surveillance of antiviral drug resistance of influenza A/H3N2 virus in Singapore, 2009-2013.

Lee Hong Kai HK   Tang Julian Wei-Tze JW   Loh Tze Ping TP   Hurt Aeron C AC   Oon Lynette Lin-Ean LL   Koay Evelyn Siew-Chuan ES  

PloS one 20150130 1


Adamantanes and neuraminidase inhibitors (NAIs) are two classes of antiviral drugs available for the chemoprophylaxis and treatment of influenza infections. To determine the frequency of drug resistance in influenza A/H3N2 viruses in Singapore, large-scale sequencing of neuraminidase (NA) and matrix protein (MP) genes was performed directly without initial culture amplification. 241 laboratory-confirmed influenza A/H3N2 clinical samples, collected between May 2009 and November 2013 were included  ...[more]

Similar Datasets

| S-EPMC6053203 | biostudies-literature
| S-EPMC3358206 | biostudies-literature
| S-EPMC8671502 | biostudies-literature
| S-EPMC4986580 | biostudies-literature
| S-EPMC2838802 | biostudies-literature
| PRJNA530277 | ENA
| PRJNA419207 | ENA
| PRJNA494885 | ENA
| S-EPMC3596303 | biostudies-literature
| S-EPMC4023734 | biostudies-literature